drugset / Trial / NCT00346879
Study to Determine Effective Dosing of Fondaparinux in Obese Persons
RandomizedSingle-groupOpen-labelTreatment
Summary
This is a prospective open-label study comparing two dosing regimens of fondaparinux, which is used to prevent deep vein thrombosis, in morbidly obese volunteers.
Timeline
- Start
- 2006-08
- Primary completion
- 2008-12
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fondaparinux | Other / unclassified | 0.03 mg/kg | — |
| Subject | Fondaparinux | Other / unclassified | 2.5 mg | — |